Evidence map›Paper›PMID 29456819›Full record

ArticleIranian journal of basic medical sciences2018

Comparison of the efficacy of piascledine and transforming growth factor β1 on chondrogenic differentiation of human adipose-derived stem cells in fibrin and fibrin-alginate scaffolds.

Batool Hashemibeni, Ali Valiani, Mojtaba Esmaeli, Mohammad Kazemi, Maryam Aliakbari, Farhad Golshan Iranpour

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of basic medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Batool HashemibeniDepartment of Anatomical Sciences, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Ali ValianiDepartment of Anatomical Sciences, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Mojtaba EsmaeliDepartment of Anatomical Sciences, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad KazemiDepartment of Molecular Biology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam AliakbariDepartment of Anatomical Sciences, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Farhad Golshan IranpourDepartment of Anatomical Sciences, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study was to compare the chondrogenic induction potential of Piascledine and TGF-β1 on adipose-derived stem cells (ADSCs) in fibrin and fibrin-alginate scaffolds. MATERIALS AND

methodsHuman subcutaneous adipose tissues were harvested from three patients who were scheduled to undergo liposuction. Isolated ADSCs were proliferated in a culture medium. Then, the cells were seeded in fibrin or fibrin-alginate scaffolds and cultured for 14 days in a chondrogenic medium containing Piascledine, TGF-β1, or both. The rate of cell proliferation and survival was evaluated by using MTT [3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide] assay and the rate of the expression of type II collagen, aggrecan, and type X collagen genes was evaluated by real-time polymerase chain reaction (real-time PCR) method.

resultsThe MTT results showed that Piascledine is able to enhance the proliferation and survival of ADSCs in fibrin scaffolds in comparison to other groups (

conclusionPiascledine can enhance the proliferation and differentiation of ADSCs in fibrin scaffolds.

Indexed as

ChondrogenesisPiascledineStem cellsTissue engineeringTransforming growth-factor beta 1

Identifiers

PMID29456819
PMCPMC5811761
OpenAlexW2786919009

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.